Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Measurement of human plasma proteome dynamics with (2)H(2)O and liquid chromatography tandem mass spectrometry.

Price JC, Holmes WE, Li KW, Floreani NA, Neese RA, Turner SM, Hellerstein MK.

Anal Biochem. 2012 Jan 1;420(1):73-83. doi: 10.1016/j.ab.2011.09.007. Epub 2011 Sep 14.

PMID:
21964502
2.

Measurement of cell proliferation by heavy water labeling.

Busch R, Neese RA, Awada M, Hayes GM, Hellerstein MK.

Nat Protoc. 2007;2(12):3045-57.

PMID:
18079703
3.

The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjects.

Hudgins LC, Baday A, Hellerstein MK, Parker TS, Levine DM, Seidman CE, Neese RA, Tremaroli JD, Hirsch J.

J Nutr Biochem. 2008 Apr;19(4):237-45. Epub 2007 Jul 6.

4.

Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice.

Turner SM, Roy S, Sul HS, Neese RA, Murphy EJ, Samandi W, Roohk DJ, Hellerstein MK.

Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1101-9. Epub 2006 Dec 12.

5.

Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans.

Vedala A, Wang W, Neese RA, Christiansen MP, Hellerstein MK.

J Lipid Res. 2006 Nov;47(11):2562-74. Epub 2006 Aug 23.

6.

Measurement of protein turnover rates by heavy water labeling of nonessential amino acids.

Busch R, Kim YK, Neese RA, Schade-Serin V, Collins M, Awada M, Gardner JL, Beysen C, Marino ME, Misell LM, Hellerstein MK.

Biochim Biophys Acta. 2006 May;1760(5):730-44. Epub 2006 Jan 24.

PMID:
16567052
7.

Sources of plasma glucose and liver glycogen in fasted ob/ob mice.

Turner SM, Linfoot PA, Neese RA, Hellerstein MK.

Acta Diabetol. 2005 Dec;42(4):187-93.

PMID:
16382307
8.

Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis.

Chen JL, Peacock E, Samady W, Turner SM, Neese RA, Hellerstein MK, Murphy EJ.

J Biol Chem. 2005 Jul 8;280(27):25396-402. Epub 2005 May 11.

9.

Dynamics of keratinocytes in vivo using HO labeling: a sensitive marker of epidermal proliferation state.

Hsieh EA, Chai CM, de Lumen BO, Neese RA, Hellerstein MK.

J Invest Dermatol. 2004 Sep;123(3):530-6.

10.

Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection.

Hellerstein MK, Hoh RA, Hanley MB, Cesar D, Lee D, Neese RA, McCune JM.

J Clin Invest. 2003 Sep;112(6):956-66.

11.

Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA.

Turner SM, Murphy EJ, Neese RA, Antelo F, Thomas T, Agarwal A, Go C, Hellerstein MK.

Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E790-803. Epub 2003 Jun 24.

12.

Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA.

Neese RA, Misell LM, Turner S, Chu A, Kim J, Cesar D, Hoh R, Antelo F, Strawford A, McCune JM, Christiansen M, Hellerstein MK.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15345-50. Epub 2002 Nov 7.

13.

Measuring synthesis rates of muscle creatine kinase and myosin with stable isotopes and mass spectrometry.

Papageorgopoulos C, Caldwell K, Schweingrubber H, Neese RA, Shackleton CH, Hellerstein M.

Anal Biochem. 2002 Oct 1;309(1):1-10.

PMID:
12381355
14.

Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.

Bandsma RH, Rake JP, Visser G, Neese RA, Hellerstein MK, van Duyvenvoorde W, Princen HM, Stellaard F, Smit GP, Kuipers F.

J Pediatr. 2002 Feb;140(2):256-60.

PMID:
11865283
15.

Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation.

Neese RA, Siler SQ, Cesar D, Antelo F, Lee D, Misell L, Patel K, Tehrani S, Shah P, Hellerstein MK.

Anal Biochem. 2001 Nov 15;298(2):189-95.

PMID:
11700973
16.

Lipoprotein secretion and triglyceride stores in the heart.

Bjorkegren J, Véniant M, Kim SK, Withycombe SK, Wood PA, Hellerstein MK, Neese RA, Young SG.

J Biol Chem. 2001 Oct 19;276(42):38511-7. Epub 2001 Jul 31.

17.

Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.

Wang W, Basinger A, Neese RA, Shane B, Myong SA, Christiansen M, Hellerstein MK.

Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E540-7.

18.

Dependence of plasma alpha-tocopherol flux on very low-density triglyceride clearance in humans.

Parks EJ, Dare D, Frazier KB, Hellerstein MK, Neese RA, Hughes E, Traber MG.

Free Radic Biol Med. 2000 Dec;29(11):1151-9.

PMID:
11121723
19.

Effects of isoenergetic overfeeding of either carbohydrate or fat in young men.

Lammert O, Grunnet N, Faber P, Bjørnsbo KS, Dich J, Larsen LO, Neese RA, Hellerstein MK, Quistorff B.

Br J Nutr. 2000 Aug;84(2):233-45.

PMID:
11029975
20.

Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes.

Christiansen MP, Linfoot PA, Neese RA, Hellerstein MK.

Diabetes. 2000 Oct;49(10):1691-9.

PMID:
11016453

Supplemental Content

Loading ...
Support Center